ロード中...
Myostatin Is a Quantifiable Biomarker for Monitoring Pharmaco-gene Therapy in Duchenne Muscular Dystrophy
Recently, several promising treatments have emerged for neuromuscular disorders, highlighting the need for robust biomarkers for monitoring therapeutic efficacy and maintenance of the therapeutic effect. Several studies have proposed circulating and tissue biomarkers, but none of them has been valid...
保存先:
| 出版年: | Mol Ther Methods Clin Dev |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Gene & Cell Therapy
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7363622/ https://ncbi.nlm.nih.gov/pubmed/32695843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2020.06.016 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|